clinical

Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review.

Mah GT, Mabasa VH, Chow I, Ensom MHH. Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review. Ann Pharmacother. 2012;46(2):265-75. DOI: 10.1345/aph.1Q378. PubMed PMID: 22274145.

Differentiating first episode substance induced and primary psychotic disorders with concurrent substance use in young people.

Fraser S, Hides L, Philips L, Proctor D, Lubman DI. Differentiating first episode substance induced and primary psychotic disorders with concurrent substance use in young people. Schizophrenia Res. 2012;136(1-3):110-5. DOI: 10.1016/j.schres.2012.01.022. PubMed PMID: 22321667.

Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial.

Hooton TM, Roberts PL, Stapleton AE. Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial. JAMA. 2012;307(6):583-9. DOI: 10.1001/jama.2012.80. PubMed PMID: 22318279.

Does this patient have an infection of a chronic wound?

Reddy M, Gill SS, Wu W, Kalkar SR, Rochon PA. Does this patient have an infection of a chronic wound?. JAMA. 2012;307(6):605-11. DOI: 10.1001/jama.2012.98. PubMed PMID: 22318282.

Rash in an immunocompromised patient.

Munoz J, Kuriakose P. Rash in an immunocompromised patient. JAMA. 2012;307(6):612-3. DOI: 10.1001/jama.2012.96. PubMed PMID: 22318283.